Der opnås lignende resultater hos normale forsøgspersoner og patienter med forskellige kombinationer af lever -, CNS - og nyrelidelser med nyre- clearance af gadoversetamid på cirka 95% af den totale plasma- clearance.
Similar results are obtained in normal subjects and patients with various combinations of liver, CNS and renal dysfunctions with renal clearance of gadoversetamide being approximately 95% of the total plasma clearance.